Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Multiple drugs

DRESS syndrome and off label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
The occurrence of DRESS syndrome after fondaparinux-sodium initiation was captured as reported in the source document.
 
Literatur
Zurück zum Zitat Minenna E, et al. Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis. Postepy Dermatologii i Alergologii 39: 816-818, No. 4, Jan 2022 Minenna E, et al. Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis. Postepy Dermatologii i Alergologii 39: 816-818, No. 4, Jan 2022
Metadaten
Titel
Multiple drugs
DRESS syndrome and off label use: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42844-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Sulphan-blue

Case report

Milrinone

Case report

Multiple drugs